1 March 2024 - The March 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are two new listings of note this month:

• Meningococcal Group B vaccine (multicomponent) (Bexsero) - restriction change
• Varicella zoster virus vaccine (adjuvanted) (Shingrix) - new vaccine
• Sacubitril with valsartan (Entresto) - restriction change
• Nivolumab (Opdivo) - restriction change
• Pembrolizumab (Keytruda) - restriction change

Read New Zealand Pharmaceutical Schedule update